What Can You Expect at the Premier European Bispecific Forum in 2026?
With Bispecific investment surging and multi-billion-dollar deals redefining the competitive landscape, the race is on to unlock new targets and next-generation multispecifics.
The Inaugural World Bispecific Summit Europe delivers:
- Exclusive perspectives
- Never-seen-before data
- Practical strategies from teams leading the field,
Gain actionable insights to accelerate innovative Bispecific design and translation to stay ahead of industry momentum
Unmissable Event Highlights for 2026:
De-Risk Bispecific, T-Cell Engager & Bispecific ADC Development from Concept to Clinic
Learn how leading biopharma teams are reducing toxicity, improving translation, and accelerating clinical progress
Insights from: Roche, Sanofi and AstraZeneca
Unlock Solid Tumour Success with Next-Generation Bispecifics
Explore innovative formats and targeting strategies designed to overcome historical efficacy and delivery challenges
Insights from: Philochem, Adaptam Therapeutics, Molecular Partners, Enara Bio & more
Design Safer, More Potent Immune-Engaging Therapies
Understand how smarter engineering and logic-gated approaches can expand the therapeutic window
Insights from: Genmab, LabGenius and Biomunex Pharmaceuticals
Stay Ahead of Emerging Targets, Modalities & Multispecific Innovation
Gain early insight into the next wave of bispecific, trispecific, and multispecific strategies shaping future pipelines
Insights from: UCB, Valink Therapeutics, NovelGen and Light Chain Bioscience
Explore the Full Event Guide
- Hear from 25+ world-class speakers across pharma and biotech sharing cutting-edge data on bispecific antibodies, T-cell engagers, and next-generation multispecific formats advancing toward clinical success
- Connect with 60+ senior attendees driving innovation in solid tumour targeting, immune cell redirection, and next-generation engineering strategies
- Gain insights from 20+ data-driven presentations covering translational challenges, safety optimisation, potency enhancement and strategies to improve clinical durability
- Take part in a dedicated Scientific Poster Session, spotlighting novel targets, platform technologies, and preclinical-to-clinical translation data
- Unlock 7+ hours of high-value networking, designed to foster strategic collaborations, partnerships, and pipeline acceleration
Attending Companies Include
![CB-CDx-0690-min-scaled11[1]](https://bispecific-europe.com/wp-content/uploads/sites/317/2024/06/CB-CDx-0690-min-scaled111.jpg "CB-CDx-0690-min-scaled11[1]")
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
![CB-CDx-0330-min-scaled11[1]](https://bispecific-europe.com/wp-content/uploads/sites/317/2024/06/CB-CDx-0330-min-scaled111.jpg "CB-CDx-0330-min-scaled11[1]")
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
![Join-Biopharma-Experts11[1]](https://bispecific-europe.com/wp-content/uploads/sites/317/2024/06/Join-Biopharma-Experts111.png "Join-Biopharma-Experts11[1]")
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.